A drug company said Friday that a medicine it sells to tamp down inflammation has helped prevent the need for breathing machines in hospitalized COVID-19 patients in the first large study that...
A drug company says that adding an anti-inflammatory medicine to a drug already widely used for hospitalized COVID-19 patients shortens their time to recovery by an additional day.
Excitement about treating the new coronavirus with malaria drugs is raising hopes, including with President Donald Trump. But the evidence that they may help is thin, and a run on the drugs is...
President Donald Trump focused attention on possible treatments for the new coronavirus on Thursday, citing potential use of a drug long used to treat malaria and some other approaches still in...
Former No. 1 and 2018 Australian Open champion Caroline Wozniacki will retire from professional tennis after competing in Melbourne next year.
TRENTON, N.J. (AP) — They were the drugs that were supposed to save the U.S. tens of billions of dollars.
Called "biosimilars," they are near-copies of complex and expensive biologic drugs...
SINGAPORE (AP) — Caroline Wozniacki was diagnosed with rheumatoid arthritis before the U.S. Open, the Danish tennis player revealed at the WTA Finals on Thursday.
She made the announcement after being eliminated from the year-end competition following a 5-7, 7-5, 6-3 loss to Elina Svitolina in her third round-robin match.
LANSING, Mich. (AP) — Michigan regulators have significantly expanded the list of conditions approved for treatment by medical marijuana.
NEW YORK (AP) — An aging kangaroo who calls the Bronx Zoo home is receiving cryotherapy treatment for arthritis.
The treatment is a high-tech alternative to ice baths that humans have used for years.
Zoo director Jim Breheny tells the Daily News that the nearly 15-year-old marsupial named Dave is getting up there and his stiff joints are aching.
TRENTON, N.J. (AP) — Could there be a second life for the once-popular arthritis pill Vioxx? A startup pharmaceutical company hopes so.
Merck & Co. voluntarily pulled the blockbuster drug in 2004 amid evidence that it doubled the chances of having a heart attack or stroke.
TRENTON, N.J. (AP) — The Latest on the possible return of Vioxx (all times local):
10:30 a.m.
Could the once-popular arthritis pill Vioxx (VEYE-ochs) get a second life? A startup pharmaceutical company hopes so.
In 2004, Merck & Co. voluntarily pulled the blockbuster drug amid evidence it doubled the chances of having a heart attack or stroke.
ERIE, Pa. (AP) — Morning was the worst time of day when Catie Britt was 2 years old.
The joints in the Millcreek Township girl's legs would swell so badly overnight that getting out of bed felt like torture.
"I remember one morning, it was time to get up and Catie was crying in her bed," said her father, Chris Britt. "Her knees hurt so much that she couldn't get her feet to the floor."
Tummy tucks really hurt. Doctors carve from hip to hip, slicing off skin, tightening muscles, tugging at innards. Patients often need strong painkillers for days or even weeks, but Mary Hernandez went home on just over-the-counter ibuprofen.
The reason may be the yellowish goo smeared on her 18-inch wound as she lay on the operating table. The Houston woman was helping test a novel medicine aimed at avoiding opioids, potent pain relievers fueling an epidemic of overuse and addiction.
Eli Lilly said U.S. regulators have rejected its much-anticipated pill for the immune disorder rheumatoid arthritis, the drugmaker's second drug development setback since November.
The Food and Drug Administration said in a letter to the company that it needed more information about the drug's safety and the best doses, Lilly said Friday in a statement.
NEW ORLEANS (AP) — A new study may reassure millions of arthritis sufferers seeking pain relief without bad side effects. It finds that Celebrex, a drug similar to ones withdrawn 12 years ago for safety reasons, is no riskier for the heart than some other painkillers that are tough on the stomach.
TRENTON, N.J. (AP) — A cheaper version of Johnson & Johnson's top-selling drug, the pricey rheumatoid arthritis treatment Remicade, could be available in the U.S. two years early after a federal judge ruled that a key patent on the drug is invalid.
WASHINGTON (AP) — The second-biggest selling drug in the world could get some cheaper competition in the U.S., after a federal panel endorsed an alternative version of the pricey medication used to treat rheumatoid arthritis and other inflammatory diseases.
A panel of Food and Drug Administration advisers voted unanimously in favor of Amgen's version of AbbVie's Humira, a biotech drug that raked in nearly $15 billion last year, according to IMS Health. While not binding,...